Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Am J Nurs ; 121(8): 16, 2021 08 01.
Article in English | MEDLINE | ID: covidwho-1546036
2.
Value Health ; 24(5): 632-640, 2021 05.
Article in English | MEDLINE | ID: covidwho-1121933

ABSTRACT

OBJECTIVE: To estimate the overall quality-adjusted life-years (QALYs) gained by averting 1 coronavirus disease 2019 (COVID-19) infection over the duration of the pandemic. METHODS: A cohort-based probabilistic simulation model, informed by the latest epidemiological estimates on COVID-19 in the United States provided by the Centers for Disease Control and Prevention and literature review. Heterogeneity of parameter values across age group was accounted for. The main outcome studied was QALYs for the infected patient, patient's family members, and the contagion effect of the infected patient over the duration of the pandemic. RESULTS: Averting a COVID-19 infection in a representative US resident will generate an additional 0.061 (0.016-0.129) QALYs (for the patient: 0.055, 95% confidence interval [CI] 0.014-0.115; for the patient's family members: 0.006, 95% CI 0.002-0.015). Accounting for the contagion effect of this infection, and assuming that an effective vaccine will be available in 3 months, the total QALYs gains from averting 1 single infection is 1.51 (95% CI 0.28-4.37) accrued to patients and their family members affected by the index infection and its sequelae. These results were robust to most parameter values and were most influenced by effective reproduction number, probability of death outside the hospital, the time-varying hazard rates of hospitalization, and death in critical care. CONCLUSION: Our findings suggest that the health benefits of averting 1 COVID-19 infection in the United States are substantial. Efforts to curb infections must weigh the costs against these benefits.


Subject(s)
COVID-19/prevention & control , Health Care Costs/statistics & numerical data , Preventive Medicine/standards , Quality-Adjusted Life Years , COVID-19/epidemiology , Cost-Benefit Analysis , Health Care Costs/trends , Humans , Pandemics/prevention & control , Pandemics/statistics & numerical data , Preventive Medicine/economics , Preventive Medicine/methods , United States
3.
Sci Rep ; 11(1): 5304, 2021 03 05.
Article in English | MEDLINE | ID: covidwho-1118815

ABSTRACT

We propose a novel data-driven framework for assessing the a-priori epidemic risk of a geographical area and for identifying high-risk areas within a country. Our risk index is evaluated as a function of three different components: the hazard of the disease, the exposure of the area and the vulnerability of its inhabitants. As an application, we discuss the case of COVID-19 outbreak in Italy. We characterize each of the twenty Italian regions by using available historical data on air pollution, human mobility, winter temperature, housing concentration, health care density, population size and age. We find that the epidemic risk is higher in some of the Northern regions with respect to Central and Southern Italy. The corresponding risk index shows correlations with the available official data on the number of infected individuals, patients in intensive care and deceased patients, and can help explaining why regions such as Lombardia, Emilia-Romagna, Piemonte and Veneto have suffered much more than the rest of the country. Although the COVID-19 outbreak started in both North (Lombardia) and Central Italy (Lazio) almost at the same time, when the first cases were officially certified at the beginning of 2020, the disease has spread faster and with heavier consequences in regions with higher epidemic risk. Our framework can be extended and tested on other epidemic data, such as those on seasonal flu, and applied to other countries. We also present a policy model connected with our methodology, which might help policy-makers to take informed decisions.


Subject(s)
COVID-19/epidemiology , Data Science/methods , Pandemics/prevention & control , COVID-19/prevention & control , COVID-19/transmission , COVID-19/virology , Geography , Health Policy , Humans , Italy/epidemiology , Pandemics/statistics & numerical data , Policy Making , Preventive Medicine/standards , Risk Assessment/methods , Risk Factors , SARS-CoV-2/pathogenicity , Time Factors
4.
J Prev Med Public Health ; 54(1): 22-30, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1097323

ABSTRACT

OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic is a public health emergency posing unprecedented challenges for health authorities. Social media may serve as an effective platform to disseminate health-related information. This study aimed to assess the extent of social media use, its impact on preventive behavior, and negative health effects such as cyberchondria and information overload. METHODS: A cross-sectional observational study was conducted between June 10, 2020 and August 9, 2020 among people visiting the outpatient department of the authors' institution, and participants were also recruited during field visits for an awareness drive. Questions were developed on preventive behavior, and the Short Cyberchondria Scale and instruments dealing with information overload and perceived vulnerability were used. RESULTS: The study recruited 767 participants with a mean age of about 45 years. Most of the participants (>90%) engaged in preventive behaviors, which were influenced by the extent of information received through social media platforms (ß=3.297; p<0.001) and awareness of infection when a family member tested positive (ß=29.082; p<0.001) or a neighbor tested positive (ß=27.964; p<0.001). The majority (63.0%) of individuals often searched for COVID-19 related news on social media platforms. The mean±standard deviation scores for cyberchondria and information overload were 9.09±4.05 and 8.69±2.56, respectively. Significant and moderately strong correlations were found between cyberchondria, information overload, and perceived vulnerability to COVID-19. CONCLUSIONS: This study provides evidence that the use of social media as an information- seeking platform altered preventive behavior. However, excessive and misleading information resulted in cyberchondria and information overload.


Subject(s)
Electronic Data Processing/instrumentation , Preventive Medicine/methods , Social Media/instrumentation , Adolescent , Adult , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/transmission , Cross-Sectional Studies , Electronic Data Processing/methods , Female , Humans , India/epidemiology , Male , Middle Aged , Pandemics/prevention & control , Preventive Medicine/standards , Preventive Medicine/statistics & numerical data , Public Health , Social Media/trends , Surveys and Questionnaires
5.
Clin J Oncol Nurs ; 25(1): 48-55, 2021 Feb 01.
Article in English | MEDLINE | ID: covidwho-1081409

ABSTRACT

BACKGROUND: The COVID-19 pandemic has required healthcare systems to transform the delivery of care. Although the core principles of care for patients with cancer have not changed, this pandemic has led to heightened awareness concerning the fragility of patients with cancer and how healthcare systems can protect them. OBJECTIVES: The aims were to identify and implement inpatient and ambulatory care clinical practice changes during the COVID-19 pandemic, based on defining moments and coping strategies from clinical oncology nurses, advanced practice RNs, nurse leaders, and researchers. METHODS: This article presents a Lean Six Sigma framework, accompanied by numerous rapid cycle tests of change. FINDINGS: The COVID-19 pandemic required clinical healthcare providers at the authors' institution to focus on seven priority areas. Nurses tested and implemented practice changes.


Subject(s)
Adaptation, Psychological , Ambulatory Care/standards , COVID-19/nursing , Health Personnel/psychology , Neoplasms/nursing , Oncology Nursing/standards , Preventive Medicine/standards , Adult , Female , Humans , Male , Middle Aged , Pandemics/prevention & control , Practice Guidelines as Topic , SARS-CoV-2 , Stress, Psychological
6.
Euro Surveill ; 26(3)2021 01.
Article in English | MEDLINE | ID: covidwho-1041841

ABSTRACT

When facing an emerging virus outbreak such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a quick reaction time is key to control the spread. It takes time to develop antivirals and vaccines, and implement vaccination campaigns. Therefore, preventive measures such as rapid isolation of cases and identification and early quarantine of cases' close contacts-as well as masks, physical distancing, hand hygiene, surface disinfection and air control-are crucial to reduce the risk of transmission. In this context, disinfectants and antiseptics with proven efficacy against the outbreak virus should be used. However, biocidal formulations are quite complex and may include auxiliary substances such as surfactants or emollients in addition to active substances. In order to evaluate disinfectants' efficacy objectively, meaningful efficacy data are needed. Therefore, the European Committee for Standardisation technical committee 216 'Chemical disinfectants and antiseptics' Working Group 1 (medical area) has developed standards for efficacy testing. The European tiered approach grades the virucidal efficacy in three levels, with corresponding marker test viruses. In the case of SARS-CoV-2, disinfectants with proven activity against vaccinia virus, the marker virus for the European claim 'active against enveloped viruses', should be used to ensure effective hygiene procedures to control the pandemic.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Anti-Infective Agents, Local/standards , COVID-19/prevention & control , Disinfectants/pharmacology , Disinfectants/standards , Preventive Medicine/standards , Virus Diseases/prevention & control , Guidelines as Topic , Humans , Pandemics/prevention & control , SARS-CoV-2
7.
Front Public Health ; 8: 572042, 2020.
Article in English | MEDLINE | ID: covidwho-983741

ABSTRACT

An outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 started in China's Hubei province at the end of 2019 has rapidly become a pandemic. In Italy, a great number of patients was managed in primary care setting and the role of general practitioners and physicians working in the first-aid emergency medical service has become of utmost importance to coordinate the network between the territory and hospitals during the pandemic. Aim of this manuscript is to provide a guidance model for the management of suspected, probable, or confirmed cases of SARS-CoV-2 infection in the primary care setting, from diagnosis to treatment, applying also the recommendations of the Italian Society of General Medicine. Moreover, this multidisciplinary contribution would analyze and synthetize the preventive measures to limit the spread of SARS-CoV-2 infection in the general population as well as the perspective for vaccines.


Subject(s)
COVID-19/prevention & control , Disease Outbreaks/prevention & control , Pandemics/prevention & control , Practice Guidelines as Topic , Preventive Medicine/standards , Primary Health Care/standards , Humans , Italy
9.
J Hosp Infect ; 106(3): 610-612, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-695672

ABSTRACT

This article reports the observed rate of infection with severe acute respiratory syndrome coronavirus-2 in healthcare workers (HCWs) who worked on wards dedicated to care of patients with coronavirus disease 2019 (COVID-19) compared with HCWs who worked on non-COVID-19 wards. The infection rate was significantly higher among HCWs who worked on non-COVID-19 wards (odds ratio 2.3, P=0.005), illustrating the need to strengthen social distancing measures and training.


Subject(s)
Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Health Personnel/education , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Preventive Medicine/education , Preventive Medicine/standards , Psychological Distance , Adult , Betacoronavirus , COVID-19 , Female , Humans , Male , Middle Aged , Occupational Exposure/prevention & control , Risk Factors , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL